Results 201 to 210 of about 908,037 (360)

Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial. [PDF]

, 1987
M P Barnes, D. Bates, N.E.F. Cartlidge, J. M. French, D.A. Shaw   +4 more
openalex   +1 more source

Spermidine reproduces the anti‐inflammatory effects of intermittent fasting and prevents urate and calcium pyrophosphate crystal‐induced inflammation

Arthritis &Rheumatology, Accepted Article.
Background Gout due to the formation of monosodium urate (MSU) crystals and calcium pyrophosphate (CPP) deposition disease are two major types of microcrystalline pathologies in adults. They are responsible for recurrent flares that rely on interleukin (IL)‐1β via activation of the NLRP3 inflammasome.
Chinh Nghia Pham, Florence Castelli, Flora Finet, Charles Leroy, Céline Chollet, Twinu Wilson Chirayath, Subhalaxmi Moitra, Mylène Zarka, Agnès Ostertag, François Brial, Christèle Combes, Augustin Latourte, Thomas Bardin, François Fenaille, Pascal Richette, Hang Korng Ea   +15 more
wiley   +1 more source

A placebo-controlled study of the doses and efficacy of Lentinula edodes mycelia for oxaliplatin-induced peripheral neuropathy in colorectal cancer. [PDF]

Front Oncol
Boku S, Satake H, Mitani S, Maeda K, Kudo T, Yamaguchi T, Takagi T, Kawakami H.   +7 more
europepmc   +1 more source

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

New England Journal of Medicine, 2017
P. Mease, S. Hall, O. FitzGerald, D. M. van der Heijde, J. Merola, F. Ávila‐Zapata, D. Cieślak, D. Graham, Cunshan Wang, S. Menon, T. Hendrikx, K. Kanik   +11 more
semanticscholar   +1 more source

Expert insight into the education of healthcare professionals on medication adherence

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Medication non‐adherence is a global health problem affecting patients with numerous medical conditions. Training healthcare professionals (HCPs) on managing the challenging issue of medication non‐adherence requires an evidence‐based approach.
Fatima Rezae, Stephen Carter, Rebekah Moles, Ayano Kelly   +3 more
wiley   +1 more source

Fool's-gold science : The ethical and scientific perils of testing most vaccines using placebo-controlled randomized trials. [PDF]

EMBO Rep
Caplan A, Pasadyn FL, Mamo N.
europepmc   +1 more source

On blaming the placebo [PDF]

Arthritis & Rheumatism, 1991
Curtis J. Henke, Wallace V. Epstein
openaire   +3 more sources

Non-specific urethritis. A placebo-controlled trial of minocycline in conjunction with laboratory investigations.

, 1976
M J Prentice, D Taylor‐Robinson, G. W. Csonka   +2 more
openalex   +1 more source

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

New England Journal of Medicine, 2012
S. Verstovsek, R. Mesa, J. Gotlib, R. Levy, Vikas Gupta, J. Dipersio, J. Catalano, M. Deininger, Carole B. Miller, R. Silver, M. Talpaz, E. Winton, J. Harvey, M. Arcasoy, E. Hexner, R. Lyons, R. Paquette, A. Raza, K. Vaddi, S. Erickson‐Viitanen, I. Koumenis, William Sun, V. Sandor, H. Kantarjian   +23 more
semanticscholar   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source